Discovery of an uncovered region in fibrin clots and its clinical significance

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Hisada, Yohei ^a,b   Yasunaga, Masahiro ^a   Hanaoka, Shingo ^c   Saijou, Shinji ^c   Sugino, Takashi ^d   Tsuji, Atsushi ^e   Saga, Tsuneo ^e   Tsumoto, Kouhei ^b   Manabe, Shino ^f   Kuroda, Jun Ichiro ^g   Kuratsu, Jun Ichi ^g   Matsumura, Yasuhiro ^a,b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Bio Matrix Research Inc   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

^e NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^f RIKEN   (Japan)

^g KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; FIBRIN; PROTEIN BINDING;

ANIMAL; ANTIGEN ANTIBODY COMPLEX; BINDING SITE; BLOOD CLOTTING; CHEMISTRY; EPITOPE MAPPING; IMMUNOLOGY; MOUSE; PROCEDURES; PROTEIN TERTIARY STRUCTURE; ARTICLE; METHODOLOGY; PROTEIN BINDING;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES; BLOOD COAGULATION; EPITOPE MAPPING; FIBRIN; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84883759085     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02604     Document Type: Article

References (34)

1. Mosesson, M. W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3, 1894-1904 (2005). (Pubitemid 41716577)
2. Pacella, B. L., Jr., Hui, K. Y., Haber, E. & Matsueda, G. R. Induction of fibrinspecific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites. Mol Immunol 20, 521-527 (1983). (Pubitemid 13103539)
3. Brass, E. P., Forman, W. B., Edwards, R. V. &Lindan, O. Fibrin formation: the role of the fibrinogen-fibrin monomer complex. Thromb Haemost 36, 37-48 (1976).
4. Graeff, H., Hafter, R. & von Hugo, R. On soluble fibrinogen-fibrin complexes. Thromb Res 16, 575-576 (1979).
5. Drew, A. F., Liu, H., Davidson, J. M., Daugherty, C. C. & Degen, J. L. Woundhealing defects in mice lacking fibrinogen. Blood 97, 3691-3698 (2001).
6. Silvain, J. et al. Composition of coronary thrombus in acute myocardial infarction. Journal of the American College of Cardiology 57, 1359-1367 (2011).
7. Skaf, E. et al. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 96, 1731-1733 (2005). (Pubitemid 41790400)
8. Levi, M., van der Poll, T. & Buller, H. R. Bidirectional relation between inflammation and coagulation. Circulation 109, 2698-2704 (2004). (Pubitemid 38737913)
9. Idell, S. et al. Regulation of fibrin deposition by malignant mesothelioma. Am J Pathol 147, 1318-1329 (1995).
10. Im, J. H. et al. Coagulation facilitates tumour cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64, 8613-8619 (2004). (Pubitemid 39552074)
11. Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumour stroma generation and wound healing. N Engl J Med 315, 1650-1659 (1986). (Pubitemid 17052899)
12. Matsumura, Y. Cancer stromal targeting (CAST) therapy. Adv Drug Deliv Rev 64, 710-719 (2012).
13. Yasunaga, M., Manabe, S. & Matsumura, Y. New concept of cytotoxic immunoconjugate therapy targeting cancer-induced fibrin clots. Cancer Sci 102, 1396-1402 (2011).
14. Soe, G., Kohno, I., Inuzuka, K., Itoh, Y. & Matsuda, M. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood 88, 2109-2117 (1996). (Pubitemid 26307913)
15. Wada, H. et al. Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis. J Thromb Haemost 4, 1253-1258 (2006).
16. Laudano, A. P. & Doolittle, R. F. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci U S A 75, 3085-3089 (1978). (Pubitemid 8395123)
17. Kudryk, B., Rohoza, A.,Ahadi, M., Chin, J.&Wiebe, M. E.Amonoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin. Mol Immunol 20, 1191-1200 (1983). (Pubitemid 14230028)
18. Scheefers-Borchel, U., Muller-Berghaus, G., Fuhge, P., Eberle, R. & Heimburger, N. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide. Proc Natl Acad Sci U S A 82, 7091-7095 (1985). (Pubitemid 16209698)
19. Schielen,W. J., Voskuilen, M., Tesser, G. I. & Nieuwenhuizen, W. The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies. Proc Natl Acad Sci U S A 86, 8951-8954 (1989). (Pubitemid 20010343)
20. Gargan, P. E., Graffney, P. J., Pleasants, J. R. & Ploplis, V. A. A Monoclonal Antibody which Recognises an Epitopic Region Unique to the Intact Fibrin Polymeric Structure. Fibrinolysis 7, 275-283 (1993). (Pubitemid 23210026)
21. Hui, K. Y., Haber, E. & Matsueda, G. R. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 222, 1129-1132 (1983). (Pubitemid 14203781)
22. Kudryk, B., Rohoza, A., Ahadi, M., Chin, J. & Wiebe, M. E. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol 21, 89-94 (1984). (Pubitemid 14181782)
23. Rosebrough, S. F. et al. Aged venous thrombi: radioimmunoimaging with fibrinspecific monoclonal antibody. Radiology 162, 575-577 (1987). (Pubitemid 17015677)
24. Kollman, J. M., Pandi, L., Sawaya, M. R., Riley, M. & Doolittle, R. F. Crystal structure of human fibrinogen. Biochemistry 48, 3877-3886 (2009).
25. Filler, R. B., Roberts, S. J. & Girardi, M. Cutaneous two-stage chemical carcinogenesis. CSH Protoc 2007, pdb prot4837 (2007).
26. Hirakawa, S. et al. VEGF-A induces tumour and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. The Journal of experimental medicine 201, 1089-1099 (2005). (Pubitemid 40524677)
27. Prandoni, P., Falanga, A. & Piccioli, A. Cancer and venous thromboembolism. Lancet Oncol 6, 401-410 (2005). (Pubitemid 40753746)
28. Fernandez, P. M., Patierno, S. R. &Rickles, F. R. Tissue factor and fibrin in tumour angiogenesis. Semin Thromb Hemost 30, 31-44 (2004). (Pubitemid 38457299)
29. Palumbo, J. S. et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumour cells. Blood 96, 3302-3309 (2000).
30. Perk, L. R. et al. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Eur J Nucl Med Mol Imaging 37, 250-259 (2010).
31. Nagatsu, K. et al. An alumina ceramic target vessel for the remote production of metallic radionuclides by in situ target dissolution. Nuclear medicine and biology 39, 1281-1285 (2012).
32. Takano, K., Tatlisumak, T., Bergmann, A. G., Gibson, D. G., 3rd. & Fisher, M. Reproducibility and reliability of middle cerebral artery occlusion using a siliconecoated suture (Koizumi) in rats. J Neurol Sci 153, 8-11 (1997). (Pubitemid 28010059)
33. Hutamekalin, P. et al. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies. J Immunol Methods 343, 49-55 (2009).
34. Basu, A., Kligman, L. H., Samulewicz, S. J. & Howe, C. C. Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). BMC Cell Biol 2, 15 (2001)